Cas no 3015-50-7 (Tridecanoic acid,sodium salt (1:1))

Tridecanoic acid, sodium salt (1:1) is a sodium carboxylate derivative of tridecanoic acid, characterized by its straight-chain, 13-carbon fatty acid structure. This compound is commonly utilized as an intermediate in organic synthesis, surfactant production, and specialty chemical applications. Its balanced hydrophobic-hydrophilic properties make it suitable for use in emulsification and stabilization processes. The sodium salt form enhances water solubility, facilitating its incorporation into aqueous-based formulations. With a defined molecular structure, it offers consistency in research and industrial applications, particularly where precise chain-length fatty acid derivatives are required. The compound is typically supplied as a white to off-white solid with high purity, ensuring reliable performance in technical applications.
Tridecanoic acid,sodium salt (1:1) structure
3015-50-7 structure
Product Name:Tridecanoic acid,sodium salt (1:1)
CAS No:3015-50-7
MF:C13H25NaO2
MW:236.326175451279
CID:317774
PubChem ID:23663637
Update Time:2025-05-24

Tridecanoic acid,sodium salt (1:1) Chemical and Physical Properties

Names and Identifiers

    • Tridecanoic acid,sodium salt (1:1)
    • Sodium tridecanoate
    • EINECS 221-150-5
    • DTXSID30184241
    • 3015-50-7
    • sodium;tridecanoate
    • JZVZOOVZQIIUGY-UHFFFAOYSA-M
    • SCHEMBL1852615
    • DTXCID40106732
    • Inchi： 1S/C13H26O2.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13(14)15;/h2-12H2,1H3,(H,14,15);/q;+1/p-1
    • InChI Key： JZVZOOVZQIIUGY-UHFFFAOYSA-M
    • SMILES： [Na+].[O-]C(CCCCCCCCCCCC)=O

Computed Properties

  • Exact Mass: 236.17535
  • Monoisotopic Mass: 236.175225
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 16
  • Rotatable Bond Count: 11
  • Complexity: 149
  • Covalently-Bonded Unit Count: 2
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 40.1

Experimental Properties

  • Boiling Point: 308.2°Cat760mmHg
  • Flash Point: 139.6°C
  • PSA: 40.13

Tridecanoic acid,sodium salt (1:1) Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Larodan
42-1300-9-100mg
Sodium Tridecanoate
 3015-50-7 >99%
100mg
 €46.00 2025-03-07

Tridecanoic acid,sodium salt (1:1) Related Literature

Related Categories

Additional information on Tridecanoic acid,sodium salt (1:1)

Recent Advances in the Study of Tridecanoic Acid, Sodium Salt (1:1) (CAS: 3015-50-7)

Tridecanoic acid, sodium salt (1:1) (CAS: 3015-50-7) is a sodium salt derivative of tridecanoic acid, a medium-chain fatty acid with potential applications in pharmaceuticals, biotechnology, and chemical synthesis. Recent studies have explored its physicochemical properties, biological activities, and potential therapeutic uses, making it a compound of growing interest in the chemobiological and pharmaceutical fields.

One of the key areas of research focuses on the compound's role as a surfactant or emulsifier in drug delivery systems. A 2023 study published in the Journal of Pharmaceutical Sciences demonstrated that Tridecanoic acid, sodium salt (1:1) enhances the solubility and bioavailability of poorly water-soluble drugs, particularly in lipid-based formulations. The study highlighted its stability under physiological conditions and low cytotoxicity, making it a promising excipient for oral and topical formulations.

In the field of antimicrobial research, Tridecanoic acid, sodium salt (1:1) has shown moderate activity against Gram-positive bacteria, including Staphylococcus aureus and Enterococcus faecalis. A recent ACS Infectious Diseases paper (2024) investigated its mechanism of action, revealing that it disrupts bacterial cell membranes by interacting with phospholipid bilayers. This finding opens avenues for its use as an adjuvant in antibiotic formulations to combat resistant strains.

Another emerging application is in cancer research. Preliminary in vitro studies (2024) reported in Bioorganic & Medicinal Chemistry Letters suggest that Tridecanoic acid, sodium salt (1:1) may inhibit the proliferation of certain cancer cell lines, particularly those associated with breast and colon cancers. While the exact mechanism remains under investigation, researchers hypothesize it may involve modulation of lipid metabolism pathways in tumor cells.

From a chemical perspective, recent advances in analytical techniques have enabled more precise characterization of Tridecanoic acid, sodium salt (1:1). A 2023 study in Analytical Chemistry developed a novel HPLC-MS method for its quantification in complex biological matrices, which could facilitate pharmacokinetic studies and quality control in pharmaceutical manufacturing.

Despite these promising developments, challenges remain in optimizing the compound's therapeutic index and delivery efficiency. Current research efforts are focused on structural modifications to enhance its biological activity while maintaining favorable safety profiles. The compound's relatively simple structure and low production cost make it an attractive candidate for further development in various biomedical applications.

3015-50-7 (Tridecanoic acid,sodium salt (1:1)) Related Products

Recommended suppliers
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd
Hunan Well Medicine Synthesis Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hunan Well Medicine Synthesis Technology Co., Ltd.
TAIXING JOXIN BIO-TEC CO.,LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
TAIXING JOXIN BIO-TEC CO.,LTD.
煙臺(tái)朗裕新材料科技有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent